Global Smart Inhalers Market - 2019-2026
|スマート吸入器の世界市場 (2019～2026年) Global Smart Inhalers Market - 2019-2026|
|出版日: 2020年07月18日||ページ情報: 英文||
世界各国で大気汚染や喫煙者の増加などにより、喘息やCOPD (慢性閉塞性肺疾患) などの患者が増加しており、それがスマート吸入器の市場需要を促進しています。最近では、スマートフォン・アプリ対応の製品も開発・上市されました。北米・欧州諸国で世界市場の大半を占めていますが、アジア太平洋地域でも急速な市場成長が生じています。
Smart inhalers are connected to the multiple devices like mobile, laptops, personal computers etc. to monitor the patient's information related to respiratory diseases. Smart inhalers can be connected through mobile Indication which helps patients and healthcare providers to monitor important information like medication schedules and dosage reminders. Inhalers uses bluetooth technology to detect, remind patients about the inhalers use, and medication timing to take care of patients. Smart inhalers have the potential to improve patients' health to provide crucial for asthma and COPD information to keep their condition under control. The global Smart inhalers market valued USD XX million in 2018 and it is expected to grow at a CAGR of XX% to reach USD XX million by 2026.
The market is driven by the rising demand for smart inhalers owing to increasing prevalence of Asthma, COPD, due to surge in air pollution and smoking habits among the people. According to the World Health Organization in 2016, the estimated Asthma patients were over 339 million people globally which most common disease among children and geriatric population. This is growing non-communicable disease owing to surge in smoking habits and rising global air pollution. Smart inhalers can be connected via wireless technology through mobile app & web platform providing crucial for asthma collects data for doctors about each drug usage and information.
There is a rise in the launching and FDA clearance of new innovative technology implemented with patient monitoring and tracking bluetooth enabled and app based smart inhalers for Asthma and other respiratory diseases. On 23rd Jan 2020, U.S. Food and Drugs Administration (FDA) has been cleared smart inhaler cap from Cognita Labs Known as CapMedic. The device has the ability to track signals of patients which has feedback mechanism and provides guidance to use inhalers correctly.
The global Smart inhalers market is segmented based on Type, distribution channel, Indication, and region.
In terms of Type the global smart inhalers marker is bifurcated into dry powder inhalers, nasal inhalers, metered dose inhalers, and others. Among this metered dose inhalers segment has highest share in 2019 owing to increasing new technology based launching of smart inhalers by the prominent players like Merck, Novartis, Vectura Group, MannKind, Respirices and Lupin. For instance 22nd Nov 2019, Lupin Company had been launched ADHERO as smart device for metered-dose inhalers. This inhaler has facility to connect with smartphone Indication via bluetooth. It is reusable smart device which tracks and send reminders to the patient's daily medication usage and consumption patterns via smartphone through "MyAdhero" app.
Similarly, dry powder inhalers, and nasal inhalers are also growing at faster pace owing to surge in the prevalence of respiratory diseases like Asthma, COPD, and many others across the globe with surge in the population. Dry powder inhalers is growing at faster pace due to rising awareness of its advantages like it avoids drug irritation and easy to use.
Depending upon indication, the global smart inhalers market is divided into Asthma
and chronic obstructive pulmonary disease (COPD). Among this Asthma segment has the largest share owing to increasing prevalence of Asthma disease around the globe due to surge in smoking habits of the people.
Similarly chronic obstructive pulmonary disease (COPD) segment is also growing at faster pace with surge in the global COPD disease burden. According to the World Health Organization in 2016, Global Burden of COPD Disease was reported around more than 251 million cases with estimated that 3.17 million deaths caused in 2015. This is primarily due to increasing the air pollution around the globe which propels this segmental growth during the forecast period.
Depending on the distribution channel, the global smart inhalers are segmented into retail pharmacies, respiratory care centers, hospital pharmacies and online pharmacies. Among this, retail pharmacies segment has the highest market share in 2019. This growth is anticipated due rise in the retail shops of pharmacies with increasing the awareness about the non-communication diseases like Asthma, COPD etc. among the people.
Similarly, online pharmacies segment has the highest market share owing to increase in the healthcare online consulting trends with surge in the online sales through portals like Flipkart, Amazon, etc.
Furthermore respiratory care centers, and hospital pharmacies are also growing at faster pace owing to increasing the number of hospitals and respiratory centers around the globe with surge in the prevalence of respiratory diseases owing to surge in the global air pollution due to smoke. According to the World Health Organization, there were at least around 2 billion people were exposed to the toxic smoke of biomass fuel in 2016.
By region, the global Smart inhalers market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global smart inhalers market and expected to grow at the highest CAGR during the forecasted period due to presence of advanced technology adoption and surge in prevalence of respiratory diseases followed by Europe region. According to American Lung Association in 2016, there were around 3.5 million peoples and estimated around 6.1 million children under 18 years were affected due to Ashtma in North America followed by Europe. This propels the smart inhalers demand in this region with increasing the number of leading players and presence of advanced technology in this region.
The Asia-Pacific region is expected to have positive market growth due to the growing prevalence of Asthma due to surge in smoking habits and increasing air pollution. Forum of International Respiratory Societies in 2016, China has reported more than 300 million smokers with annual consumption of 2 trillion cigarettes, highest tobacco consuming nation with record of a single person dies every 30 seconds from tobacco use. Furthermore, increasing adoption of advanced technology to prevent such respiratory disorders with the help of smart inhalers with surge in population shall boost the demand for the market over the forecasted period.
The global smart inhalers market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition Merck, Novartis, Vectura Group, MannKind, Respirices, Orion Pharm, Hovione, AstraZeneca, OPKO Health Inc, Boehringer-Ingelheim, 3M, Teva, Sunovion Pharmaceuticals, Aristopharma, GlaxoSmithKline and Cohero Health LLC are the leading market players with significant market share.
Major players are receiving launching new technology sensors and app based advanced smart inhalers for curing respiratory diseases in healthcare industry. For instance on 22nd Jan 2020, Teva Company had launched the world's first smart inhaler which was approved by the FDA. Teva's smart inhaler named ProAir Digihaler which was being launched in the United States market through a sNDA Indication. The ProAir Digihaler has a sensor used in real-time tracking, monitoring the patients and collecting the syncs data through a mobile app.
Companies are entering into the collaborations, acquisitions, mergers, and licensing for increasing their market penetration. For instance, on 28th January, 2020 Aptar Pharma, a leading drug delivery services and active packaging solutions Company has been partnered with Lupin Limited to launch India's first smart connected device for metered-dose inhalers (MDI) called ADHERO.